Contact this trialFirst, we need to learn more about you.
Kinase Inhibitor
Avutometinib + Defactinib for Stomach Cancer
Recruiting1 awardPhase 2
New York, New York
This trial aims to see if using a combination of avutometinib and defactinib can help people with diffuse-type stomach cancer live longer, shrink their tumors, and do so safely.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service